UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Gross Profit Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual gross profit in 2023 was 17.89 Million TWD , up 118.36% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 3.08 Million TWD , up 206.46% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a annual gross profit of 8.19 Million TWD in annual gross profit 2022, up 40.53% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a annual gross profit of 5.83 Million TWD in annual gross profit 2021, up 149.44% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a quarterly gross profit of 1 Million TWD for 2024 Q1, down -76.31% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a quarterly gross profit of 4.24 Million TWD for 2023 Q3, down -36.44% from previous quarter.

Annual Gross Profit Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Gross Profit of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 17.89 Million TWD 118.36%
2022 8.19 Million TWD 40.53%
2021 5.83 Million TWD 149.44%
2020 2.33 Million TWD -81.27%
2019 12.48 Million TWD 0.0%

Peer Gross Profit Comparison of UnicoCell Biomed Co., Ltd.

Name Gross Profit Gross Profit Difference
Apex Biotechnology Corp. 531.11 Million TWD 96.63%
Sinphar Pharmaceutical Co.,Ltd. 1.09 Billion TWD 98.36%
Panion & Bf Biotech Inc. 912.56 Million TWD 98.039%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 757.3 Million TWD 97.637%
GenMont Biotech Incorporation 177.33 Million TWD 89.908%
Abnova (Taiwan) Corporation 173.91 Million TWD 89.709%
Adimmune Corporation 410.93 Million TWD 95.645%
Tanvex BioPharma, Inc. 59.7 Million TWD 70.022%
Polaris Group -137.9 Million TWD 112.978%
Energenesis Biomedical CO.,LTD. 5.22 Million TWD -242.395%
PELL Bio-Med Technology Co. Ltd. -26.14 Million TWD 168.466%